Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Roussou

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Blood|February 2, 2018
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosisEfstathios Kastritis, Ioannis Papassotiriou, Giampaolo Merlini, et al.
Leukemia|February 16, 2021
Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective studyEfstathios Kastritis, Ageliki Laina, Georgios Georgiopoulos, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 22, 2019
Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosisEfstathios Kastritis, Maria Gavriatopoulou, Maria Roussou, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 14, 2020
Next generation flow cytometry for MRD detection in patients with AL amyloidosisEsftathios Kastritis, Ioannis V Kostopoulos, Foteini Theodorakakou, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2020
Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With MyelomaEfstathios Kastritis, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 1, 2021
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition diseaseEfstathios Kastritis, Pantelis Rousakis, Ioannis V Kostopoulos, et al.
European Journal of Haematology|July 21, 2018
Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practiceEvangelos Terpos, Eirini Katodritou, Javier de la Rubia, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 28, 2020
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosisEfstathios Kastritis, Despina Fotiou, Foteini Theodorakakou, et al.
Circulation Research|August 13, 2019
Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain AmyloidosisKimon Stamatelopoulos, Georgios Georgiopoulos, Fani Athanasouli, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 20, 2024
VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)Efstathios Kastritis, Meral Beksac, Sorina Nicoleta Badelita, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Blood|February 2, 2018
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosisEfstathios Kastritis, Ioannis Papassotiriou, Giampaolo Merlini, et al.
Leukemia|February 16, 2021
Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective studyEfstathios Kastritis, Ageliki Laina, Georgios Georgiopoulos, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 22, 2019
Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosisEfstathios Kastritis, Maria Gavriatopoulou, Maria Roussou, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 14, 2020
Next generation flow cytometry for MRD detection in patients with AL amyloidosisEsftathios Kastritis, Ioannis V Kostopoulos, Foteini Theodorakakou, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2020
Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With MyelomaEfstathios Kastritis, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 1, 2021
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition diseaseEfstathios Kastritis, Pantelis Rousakis, Ioannis V Kostopoulos, et al.
European Journal of Haematology|July 21, 2018
Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practiceEvangelos Terpos, Eirini Katodritou, Javier de la Rubia, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 28, 2020
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosisEfstathios Kastritis, Despina Fotiou, Foteini Theodorakakou, et al.
Circulation Research|August 13, 2019
Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain AmyloidosisKimon Stamatelopoulos, Georgios Georgiopoulos, Fani Athanasouli, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 20, 2024
VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)Efstathios Kastritis, Meral Beksac, Sorina Nicoleta Badelita, et al.
Pageof 8